10月17日，皖仪科技跌5.01%，截至发稿，报21.42元/股，成交2659.29万元，换手率0.90%，总市值 28.85亿元。 鹏华研究智选混合（007146）基金经理为包兵华。 截至发稿，包兵华累计任职时间6年183天，现任基金资产总规模27.25亿元，任职期间最佳基金回报 136.01%， 任职期间最差基金回报-32.87%。 风险提示：市场有风险，投资需谨慎。本文为AI大模型自动发布，任何在本文出现的信息（包括但不 限于个股、评论、预测、图表、指标、理论、任何形式的表述等）均只作为参考，不构成个人投资建 议。 责任编辑：小浪快报 资料显示，安徽皖仪科技股份有限公司位于安徽省合肥市高新技术产业开发区文曲路8号，成立日期 2003年6月26日，上市日期2020年7月3日，公司主营业务涉及工业检测仪器、在线监测仪器、实验室分 析仪器、医疗仪器等仪器的研发、生产、销售。主营业务收入构成为：工业检测仪器及解决方案 60.84%，在线监测仪器及解决方案23.75%，实验室分析仪器及解决方案8.44%，其他(补充)6.96%。 从基金十大重仓股角度 数据显示，鹏华基金旗下1只基金重仓皖仪科技。鹏华研究智选混合（ ...

10月15日，皖仪科技涨5.22%，截至发稿，报22.98元/股，成交3540.49万元，换手率1.17%，总市值 30.96亿元。 鹏华研究智选混合（007146）成立日期2019年5月6日，最新规模3.21亿。今年以来收益30.5%，同类排 名2472/8161；近一年收益31.75%，同类排名2235/8015；成立以来收益131.25%。 从基金十大重仓股角度 风险提示：市场有风险，投资需谨慎。本文为AI大模型自动发布，任何在本文出现的信息（包括但不 限于个股、评论、预测、图表、指标、理论、任何形式的表述等）均只作为参考，不构成个人投资建 议。 数据显示，鹏华基金旗下1只基金重仓皖仪科技。鹏华研究智选混合（007146）二季度持有股数15.54万 股，占基金净值比例为1.14%，位居第十大重仓股。根据测算，今日浮盈赚取约17.72万元。 责任编辑：小浪快报 鹏华研究智选混合（007146）基金经理为包兵华。 截至发稿，包兵华累计任职时间6年181天，现任基金资产总规模27.25亿元，任职期间最佳基金回报 137.38%， 任职期间最差基金回报-32.87%。 资料显示，安徽皖仪科技股份有限公司位于安徽 ...

9月29日，皖仪科技盘中下跌2.03%，截至14:13，报21.72元/股，成交2731.00万元，换手率0.92%，总市 值29.26亿元。 资金流向方面，主力资金净流入173.39万元，大单买入394.53万元，占比14.45%，卖出221.14万元，占 比8.10%。 皖仪科技今年以来股价涨62.61%，近5个交易日涨0.14%，近20日跌1.45%，近60日跌3.89%。 皖仪科技所属申万行业为：机械设备-通用设备-仪器仪表。所属概念板块包括：科学仪器、环境监测、 小盘、医疗器械、污水处理等。 截至6月30日，皖仪科技股东户数3851.00，较上期减少0.52%；人均流通股34980股，较上期增加 0.52%。2025年1月-6月，皖仪科技实现营业收入3.08亿元，同比增长3.79%；归母净利润104.71万元，同 比增长103.63%。 分红方面，皖仪科技A股上市后累计派现1.25亿元。近三年，累计派现6511.88万元。 机构持仓方面，截止2025年6月30日，皖仪科技十大流通股东中，鑫元欣享A（005262）位居第五大流 通股东，持股200.79万股，相比上期增加6.49万股。 责任编辑：小浪快 ...

Core Viewpoint - The company is committed to enhancing operational efficiency and profitability while actively returning value to investors, in line with the Shanghai Stock Exchange's initiative for listed companies to improve quality and efficiency [2][8]. Action Plan Implementation - The company has implemented a profit distribution policy that emphasizes reasonable and stable returns to investors while ensuring sustainable development [2]. - A total cash dividend of RMB 12,532,241.10 (including tax) was distributed to shareholders based on 125,322,411 shares [3]. - The company initiated a share repurchase program in November 2023, with a total repurchase amount adjusted to between RMB 105 million and RMB 205 million [3]. - As of the report period, the company has repurchased 9,386,079 shares, totaling RMB 151,381,839.01 [4]. Performance Enhancement Measures - The company focuses on independent innovation and aims to replace imports in high-end scientific instruments, developing a complete production system for various products [4][5]. - The company has adopted a "Four Focuses and Two Enhancements" strategy to deepen its market presence in the new energy sector and expand into semiconductor and overseas markets [5]. - The company is advancing its product lines in laboratory analysis instruments, particularly in ion chromatography and liquid chromatography [5][6]. Governance and Risk Management - The company has restructured its governance by abolishing the supervisory board, with responsibilities transferred to the audit committee of the board [6]. - Training programs for board members and senior management have been organized to enhance compliance and operational skills [6][7]. Investor Relations and Social Responsibility - The company has conducted four shareholder meetings and engaged with 149 institutional investors to enhance transparency and investor understanding [7]. - The company published its first Environmental, Social, and Governance (ESG) report in April 2025, achieving an ESG rating upgrade to AA [7]. Future Work Plans - The company plans to continue executing the action plan, focusing on technological innovation, operational quality, governance improvement, and investor communication to enhance shareholder value [8].